COLLIN J WEBER, MD
Radiology at Clifton Rd, Atlanta, GA

License number
Georgia 036034
Category
Radiology
Type
Surgery
Address
Address
1365 Clifton Rd NE, Atlanta, GA 30322
Phone
(404) 778-5451
(404) 778-3101 (Fax)
(404) 727-0084
(404) 727-3660 (Fax)

Personal information

See more information about COLLIN J WEBER at radaris.com
Name
Address
Phone
Collin Weber, age 79
3028 Vinings Forest Way SE, Atlanta, GA 30339
(770) 433-0111
Collin J Weber, age 80
3028 Vinings Way, Atlanta, GA 30339
(770) 433-0111

Organization information

See more information about COLLIN J WEBER at bizstanding.com

Emory Clinic - Collin J Weber MD

1365 Clifton Rd NE, Atlanta, GA 30322

Categories:
General Surgeons
Phone:
(404) 778-3322 (Phone)

Professional information

Collin J Weber Photo 1

Dr. Collin J Weber, Atlanta GA - MD (Doctor of Medicine)

Specialties:
Critical Care Surgery
Address:
Emory Clinic General/Vsclr Sgry
1365 Clifton Rd NE, Atlanta 30322
(404) 778-4000 (Phone)
Certifications:
Critical Care Surgery, 1990, General Surgery, 1999
Awards:
Healthgrades Honor Roll
Languages:
English, Spanish
Hospitals:
Emory Clinic General/Vsclr Sgry
1365 Clifton Rd NE, Atlanta 30322
Emory University Hospital
1364 Clifton Rd North #East, Atlanta 30322
Education:
Medical School
Columbia University College Of Physicians and Surgeons
Graduated: 1971
Columbia Presby Med Center
Graduated: 1972


Collin J Weber Photo 2

Dr. Collin J Weber, Atlanta GA - MD (Doctor of Medicine)

Specialties:
General Surgery
Address:
EMORY CLINIC - SURGERY
1365 Clifton Rd NE SUITE A3333, Atlanta 30322
(404) 778-5451 (Phone), (404) 778-3101 (Fax)
Languages:
English
Education:
Medical School
Columbia University / College of Physicians And Surgeons


Collin James Weber Photo 3

Collin James Weber, Atlanta GA

Specialties:
Surgery, Surgical Critical Care
Work:
The Emory Clin
1365 Clifton Rd Ne, Atlanta, GA 30322 The Emory Clin
The Emory Clinic BUILDING A, Atlanta, GA 30322
Education:
Columbia University (1971)


Collin Weber Photo 4

Method Of Inhibiting Immune System Destruction Of Transplanted Viable Cells

US Patent:
7041634, May 9, 2006
Filed:
Mar 27, 1998
Appl. No.:
09/049865
Inventors:
Collin J. Weber - Atlanta GA, US
Mary K. Hagler - Loganville GA, US
Peter S. Linsley - Seattle WA, US
Judith A. Kapp - Atlanta GA, US
Susan A. Safley - Decatur GA, US
Assignee:
Emory University - Atlanta GA
Bristol Myers-Squibb Company - New York NY
International Classification:
A61K 38/00
US Classification:
514 2, 4241561, 4241371, 4241411, 424 937, 424812, 530350
Abstract:
This invention provides a method of inhibiting viable cells transplanted into a subject from being destroyed by the subject's immune system which comprises: a) containing the viable cells, or tissue comprising the viable cells, prior to transplantation within a device comprising a semipermeable membrane; and b) treating the subject with a substance which inhibits an immune-system costimulation event in an amount effective to inhibit the subject's immune system from responding to said contained cells or tissue. In one embodiment, the substance which inhibits an immune-system costimulation event is CTLA4. Also provided by this invention is a method of treating diabetes in a subject which comprises: a) containing viable insulin-producing cells, or tissue comprising such cells, within a device comprising a semipermeable membrane; b) transplanting an effective amount of such contained viable insulin-producing cells into the subject; and c) treating the subject with an effective amount of a substance which inhibits an immune-system costimulation event.


Collin Weber Photo 5

Method Of Containing Core Material In Microcapsules

US Patent:
5795570, Aug 18, 1998
Filed:
Apr 7, 1995
Appl. No.:
8/418953
Inventors:
Collin J. Weber - Atlanta GA
Assignee:
Emory University - Atlanta GA
International Classification:
A61K 3512, C12N 1110, B01J 1320
US Classification:
424 937
Abstract:
A core material such as animal tissue or cells is contained within a semipermeable vessel which may be a microcapsule, hollow fiber or plastic membrane having a semipermeable wall by a method that prevents the core material from incorporation into the wall of the vessel. This is accomplished by suspending the core material in a solution of polysaccharide gum such as an alkali metal alginate in an amount between about 0. 2% and about 0. 5%, removing and washing the core material to remove all but a thin layer of polysaccharide gum, and gelling the polysaccharide gum with multivalent cations or other means to form a pretreated core material. The pretreated core material is contained within a semipermeable vessel such as by suspending the pretreated core material in a solution of alkali metal alginate, forming the suspension into droplets, gelling the droplets to form temporary shape-retaining capsules and treating the capsules with a polymeric material having groups that react with and crosslink acid groups of the capsules to form a permanent semipermeable membrane around the capsules. A second permanent semipermeable membrane may be formed around the capsules to form double-walled microcapsules by further treating the capsules with the polymeric material. The semipermeable vessel may be impermeable to immune factors.